Trial intelligence / Profile preview

Effect of ADDE Treatments on Lipid Layer Thickness

NCT05456061Completed

Sponsor
Yonsei University
Start
Aug 2018
Primary completion
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of diquafosol in dry eye syndrome (DED) (4 arms), sponsored by Yonsei University. Primary endpoint: Average Lipid Layer Thickness at 4 weeks. Started Aug 2018; status: completed.

02

Drugs

diquafosol
03

Conditions

dry eye syndrome (DED)

Beyond the preview

Go deeper on NCT05456061.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05456061.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call